Investing in Life-Changing Therapies | Leaps by Bayer VP Venture Investments, Lucio Iannone

Lucio Iannone, VP of Venture Investments at Leaps by Bayer, shares insights on the future of biotech investment, focusing on cell therapy and inflammation treatments. Discover how Iannone's unique journey from boxing to biotech has shaped his approach to identifying and nurturing groundbreaking medical technologies.